Drug intelligence / Profile preview

Fenestra

Development stage
Unknown
Lead developer
Merck
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

Fenestra is a specialized line of iodinated lipid emulsion contrast agents designed for preclinical micro-computed tomography (micro-CT) imaging in small animal models. The product family includes Fenestra LC (Liver Contrast), Fenestra VC (Vascular Contrast), and Fenestra HD (High Density). Fenestra LC is formulated to mimic chylomicron remnants, enabling selective sequestration by hepatocytes via the low-density lipoprotein (LDL) receptor pathway. This targeted uptake allows for high-resolution imaging of the liver parenchyma and the identification of hepatic lesions, such as primary tumors or metastases, in rodent models. Fenestra VC serves as a long-circulating blood-pool agent, providing stable contrast for vascular and cardiac imaging over several hours. Originally developed by Alerion Biomedical and currently marketed by MediLumine, these agents are essential tools for longitudinal research in oncology, cardiology, and metabolic diseases, though they are not intended for human clinical use.

Brand names
Fenestra LCFenestra VCFenestra HD
Other names
Alerion FenestraFenestra ContrastIodinated lipid emulsion
02

Targets

LDLR (Low-density lipoprotein receptor)

Beyond the preview

Go deeper on Fenestra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenestra.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call